Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Preferred Shares (2017 - 2025)

Historic Preferred Shares for Fortress Biotech (FBIO) over the last 9 years, with Q3 2025 value amounting to $3000.0.

  • Fortress Biotech's Preferred Shares changed 0.0% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $3000.0 for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Preferred Shares is $3000.0, which was down 0.0% from $3000.0 recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Preferred Shares registered a high of $3000.0 during Q1 2021, and its lowest value of $3000.0 during Q1 2021.
  • In the last 5 years, Fortress Biotech's Preferred Shares had a median value of $3000.0 in 2021 and averaged $3000.0.
  • Over the last 5 years, Fortress Biotech's Preferred Shares had its largest YoY gain of 5000.0% in 2021, and its largest YoY loss of 0.0% in 2021.
  • Fortress Biotech's Preferred Shares (Quarter) stood at $3000.0 in 2021, then changed by 0.0% to $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
  • Its last three reported values are $3000.0 in Q3 2025, $3000.0 for Q2 2025, and $3000.0 during Q1 2025.